Dr Jess Dyson is the deputy lead for our Precision Medicine and Rare Diseases theme. She is an NHS consultant hepatologist at Freeman Hospital in Newcastle. Her sub-specialty interests are in autoimmune liver disease and liver transplantation. Jess leads the clinical service for patients with autoimmune liver disease. She also runs the regional service for second-line therapies for patients with high risk primary biliary cholangitis (PBC). Jess is also an honorary clinical senior lecturer at Newcastle University. She undertakes translational clinical research with a particular focus on autoimmune liver disease, risk stratification and identification of disease biomarkers. Jess is principal investigator for the UK national study for patients with autoimmune hepatitis that focuses on improving therapy for patients. She is also a member of the BASL SIG for autoimmune liver disease and the IAIHG and IPSCSG. Jess completed her PhD in 2019. Her studies investigated the potential environmental risk factors related to autoimmune liver disease. She is also a co-author on the UK guidelines for PBC, primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH).